Saedder E, Thomsen A, Hasselstrom J, Jornil J
Clin Case Rep. 2019; 7(11):2042-2048.
PMID: 31788248
PMC: 6878084.
DOI: 10.1002/ccr3.2393.
Meechan J
Anesth Prog. 1997; 44(3):106-9.
PMID: 9481971
PMC: 2148929.
Robson R, Vishwanath M
Br Med J (Clin Res Ed). 1982; 284(6309):104.
PMID: 6797645
PMC: 1495693.
DOI: 10.1136/bmj.284.6309.104.
Heidland A, HEIDBREDER E, Horl W, Schafer R
Klin Wochenschr. 1983; 61(13):633-40.
PMID: 6350692
DOI: 10.1007/BF01487579.
Lewis J
Drugs. 1983; 25(2):196-222.
PMID: 6339200
DOI: 10.2165/00003495-198325020-00006.
Adverse reactions and interactions with beta-adrenoceptor blocking drugs.
Lewis R, McDevitt D
Med Toxicol. 1986; 1(5):343-61.
PMID: 2878346
DOI: 10.1007/BF03259848.
The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.
Soward A, Vanhaleweyk G, Serruys P
Drugs. 1986; 32(1):66-101.
PMID: 2874975
DOI: 10.2165/00003495-198632010-00004.
Are beta blockers and nifedipine safe?.
Stockley I
BMJ. 1989; 298(6687):1584.
PMID: 2569337
PMC: 1836805.
DOI: 10.1136/bmj.298.6687.1584-a.
Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.
Sorkin E, Clissold S, Brogden R
Drugs. 1985; 30(3):182-274.
PMID: 2412780
DOI: 10.2165/00003495-198530030-00002.
Comparison of the cardiovascular effects of nifedipine and nicardipine in the presence of atenolol.
Thomas S
Eur J Clin Pharmacol. 1991; 41(3):201-6.
PMID: 1748136
DOI: 10.1007/BF00315430.
Calcium antagonists in patients with heart failure. A review.
Reicher-Reiss H, Barasch E
Drugs. 1991; 42(3):343-64.
PMID: 1720378
DOI: 10.2165/00003495-199142030-00002.
